Molecular formula:C181H291N55O51S2
Molecular weight: 4117.77 g·mol−1
Patent period: —
Dositive specifications:–
Injection :–
Oral tablets: —
Injection: —
Molecular formula:C181H291N55O51S2
Molecular weight: 4117.77 g·mol−1
Patent period: —
Dositive specifications:–
Injection :–
Oral tablets: —
Injection: —
Teriparatide is indicated for the treatment of postmenopausal women with osteoporosis;for the increase of bone mass in men with primary or hypogonadal osteoporosis;and treatment of men and women with osteoporosis associated with sustained systemic glucocorticoid therapy.
CAS NO. | 52232-67-4 |
---|---|
FORMULA | C181H291N55O51S2 |
M. WT | 4117.77 g·mol−1 |
Bioavailability | 95% |
Metabolism | Liver (nonspecific proteolysis) |
STORAGE | — |